through glycan engineering.
Our mission
The next generation of therapeutics.
kyron.bio unlocks superior protein therapeutics by harnessing the power of glycan modifications.
Our novel engineering strategy precisely controls glycosylation patterns, opening a new era of antibody therapeutics.
This has the power to deliver better therapies and transform patient outcomes.
Read more about
Our people
are dedicated to revolutionising the way we make therapeutic drugs
TEAM
ADVISORS
Marine Daou
FOUNDER'S ASSOCIATE
MEng Imperial College London
Dr. Caroline Desmurget
RESEARCH ASSOCIATE
PhD Merck Switzerland
Sabine Da Silva
EXECUTIVE ASSISTANT
BA West Chester University Pennsylvania
Dr. Emilia McLaughlin
CEO & FOUNDER
PhD Institut Pasteur Paris
Woman in Leadership (EIC)
Dr. Marina Lochhead
R&D LEAD
PostDoc Institut Curie Paris
PhD Queen's University Canada
Dr. Damien Toullec
LAB MANAGER & TECHNICIAN
PhD CNRS-CRBM Montpellier
Prof. Michael Ferguson
HEAD DRUG DISCOVERY UNIVERSITY OF DUNDEE
Bjørn Voldborg
HEAD NATIONAL BIOLOGICS DTU
Dr. René Labatut
VP SANOFI
Marie Moores
INDUSTRY ADVISOR
Proudly supported by
We would love to hear from you
and leading angel investors.
News
kyron.bio wins the Servier Spartners Golden Ticket
Kyron.bio is honoured to be the recipient of the first Golden Ticket from Servier & Spartners BioLabs, providing a year of free lab space on the Servier site and access to key mentorship from the Servier team. We are delighted to be growing our company with the support of one of the most influential players in the French ecosystem!
Read more of
Kyron.bio is awarded a €2.5M EIC Transition grant, a highly competitive European grant awarded to technologies that are ready to make the leap from the lab to the market. The grant was awarded to kyron.bio and their consortium partner, Genos Glyco, after the highest number of applicants on record. This award highlights the European Union’s recognition of the innovative potential of glycan engineering to create safer and more effective therapies for patients.
kyron.bio awarded 2025 EIC Transition
2025
Kyron.bio is proud to win the the iLab ‘Concours d’innovation’ by Bpifrance, which focuses on supporting high-potential, innovative startups working on disruptive projects. kyron.bio is honoured to be among the 23% of women-led projects awarded this highly competitive grant, receiving €360K to support internal R&D and expedite the development of its cutting-edge glycan engineering strategy.
kyron.bio wins iLab concours d'innovation
2024
2023